Jyong Biotech (MENS) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $1.98, -3.41% vs the prior close of $2.05.
- Volume 142.60K shares, 3.6x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
MENS slides 3.4% to $1.98 on 3.6x normal volume. Closed at $1.98, -3.41% vs the prior close of $2.05. Day range $1.95–$2.12, opened at $2.03.
MENS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — MENS slides 3.4% to $1.98 on 3.6x normal volume
- Closed at $1.98, -3.41% vs the prior close of $2.05. Day range $1.95–$2.12, opened at $2.03.
- Volume was 142.60K shares, 3.6x its 50-day average of 39.47K — unusually heavy trading.
- Price is -6.5% vs its 50-day average ($2.12) and -12.3% vs its 200-day average ($2.26).
- 52-week range $1.43–$63.00; today's close sits at 1% of that range, 96.9% below the 52-week high.
Oct 14, 2026 — MENS rises 0.5% to $2.05
- Closed at $2.05, +0.49% vs the prior close of $2.04. Day range $1.97–$2.12, opened at $2.06.
- Volume was 32.80K shares, 0.8x its 50-day average of 39.91K.
- Price is -3.3% vs its 50-day average ($2.12) and -9.4% vs its 200-day average ($2.26).
- 52-week range $1.43–$63.00; today's close sits at 1% of that range, 96.7% below the 52-week high.
Oct 13, 2026 — MENS dips 2.9% to $2.04, 3 down days in a row
- Closed at $2.04, -2.86% vs the prior close of $2.10. Day range $1.99–$2.11, opened at $2.10.
- Volume was 22.90K shares, 0.6x its 50-day average of 40.93K — lighter than usual.
- Price is -3.7% vs its 50-day average ($2.12) and -10.0% vs its 200-day average ($2.27).
- 52-week range $1.43–$63.00; today's close sits at 1% of that range, 96.8% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — MENS ends flat (+0.0%) to $2.10
- Closed at $2.10, +0.00% vs the prior close of $2.10. Day range $2.02–$2.15, opened at $2.15.
- Volume was 20.30K shares, 0.5x its 50-day average of 41.93K — lighter than usual.
- Price is -0.8% vs its 50-day average ($2.12) and -7.7% vs its 200-day average ($2.28).
- 52-week range $1.43–$63.00; today's close sits at 1% of that range, 96.7% below the 52-week high.
Oct 9, 2026 — MENS ends flat (+0.0%) to $2.10
- Closed at $2.10, +0.00% vs the prior close of $2.10. Day range $2.05–$2.18, opened at $2.10.
- Volume was 36.70K shares, 0.9x its 50-day average of 41.89K.
- Price is -0.9% vs its 50-day average ($2.12) and -8.1% vs its 200-day average ($2.28).
- 52-week range $1.43–$63.00; today's close sits at 1% of that range, 96.7% below the 52-week high.
Oct 8, 2026 — MENS rises 1.9% to $2.10
- Closed at $2.10, +1.94% vs the prior close of $2.06. Day range $2.00–$2.12, opened at $2.06.
- Volume was 39.30K shares, 0.9x its 50-day average of 42.50K.
- Price is -1.0% vs its 50-day average ($2.12) and -8.6% vs its 200-day average ($2.30).
- 52-week range $1.43–$63.00; today's close sits at 1% of that range, 96.7% below the 52-week high.
Oct 7, 2026 — MENS rises 2.0% to $2.06
- Closed at $2.06, +1.98% vs the prior close of $2.02. Day range $2.01–$2.10, opened at $2.07.
- Volume was 26.80K shares, 0.6x its 50-day average of 43.70K.
- Price is -3.0% vs its 50-day average ($2.12) and -10.6% vs its 200-day average ($2.30).
- 52-week range $1.43–$63.00; today's close sits at 1% of that range, 96.7% below the 52-week high.
Oct 6, 2026 — MENS dips 1.5% to $2.02
- Closed at $2.02, -1.46% vs the prior close of $2.05. Day range $2.02–$2.19, opened at $2.05.
- Volume was 20.20K shares, 0.5x its 50-day average of 43.77K — lighter than usual.
- Price is -5.2% vs its 50-day average ($2.13) and -12.6% vs its 200-day average ($2.31).
- 52-week range $1.43–$63.00; today's close sits at 1% of that range, 96.8% below the 52-week high.
Oct 5, 2026 — MENS slides 6.0% to $2.05
- Closed at $2.05, -5.96% vs the prior close of $2.18. Day range $2.02–$2.20, opened at $2.19.
- Volume was 47.40K shares, 1.1x its 50-day average of 43.98K.
- Price is -4.2% vs its 50-day average ($2.14) and -11.4% vs its 200-day average ($2.31).
- 52-week range $1.43–$63.00; today's close sits at 1% of that range, 96.7% below the 52-week high.
Oct 2, 2026 — MENS jumps 7.4% to $2.18
- Closed at $2.18, +7.39% vs the prior close of $2.03. Day range $2.05–$2.18, opened at $2.06.
- Volume was 29.70K shares, 0.7x its 50-day average of 44.91K.
- Price is +1.6% vs its 50-day average ($2.15) and -8.5% vs its 200-day average ($2.38).
- 52-week range $1.43–$63.00; today's close sits at 1% of that range, 96.5% below the 52-week high.
MENS latest news & SEC filings
Every SEC filing by or about MENS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
May 15, 2026 · Form 20-F — Annual report from a foreign company (20-F)
Annual report from a foreign company (20-F)
Fiscal year ended Dec 31, 2025:
- Net income: -$4.67M (prior year -$3.02M) (loss widened vs Dec 31, 2024)
- Diluted EPS: -$0.06 (prior year -$0.04) (loss widened vs Dec 31, 2024)
Apr 29, 2026 · Form NT 20-F — NT 20-F filing
NT 20-F filing
Apr 24, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Apr 14, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Apr 8, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Things to know before you trade MENS
- How much it moves: over the last 20 sessions the average daily move was 3.28% (largest 10.7%). That is a volatile stock.
- Liquidity: about 49.37K shares (≈$97.74K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.98 vs a range of $1.43–$63.00 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 20-F May 15, 2026; 6-K Feb 6, 2026; 6-K Jan 9, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
MENS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 2.03 | 2.12 | 1.95 | 1.98 | 142.60K |
| Oct 14, 2026 | 2.06 | 2.12 | 1.97 | 2.05 | 32.80K |
| Oct 13, 2026 | 2.10 | 2.11 | 1.99 | 2.04 | 22.90K |
| Oct 12, 2026 | 2.15 | 2.15 | 2.02 | 2.10 | 20.30K |
| Oct 9, 2026 | 2.10 | 2.18 | 2.05 | 2.10 | 36.70K |
| Oct 8, 2026 | 2.06 | 2.12 | 2.00 | 2.10 | 39.30K |
| Oct 7, 2026 | 2.07 | 2.10 | 2.01 | 2.06 | 26.80K |
| Oct 6, 2026 | 2.05 | 2.19 | 2.02 | 2.02 | 20.20K |
| Oct 5, 2026 | 2.19 | 2.20 | 2.02 | 2.05 | 47.40K |
| Oct 2, 2026 | 2.06 | 2.18 | 2.05 | 2.18 | 29.70K |
| Oct 1, 2026 | 2.01 | 2.08 | 1.97 | 2.03 | 31.30K |
| Sep 30, 2026 | 2.02 | 2.08 | 1.92 | 2.05 | 31.30K |
| Sep 29, 2026 | 2.07 | 2.07 | 1.96 | 2.03 | 17.10K |
| Sep 28, 2026 | 2.08 | 2.12 | 1.94 | 1.97 | 46.40K |
| Sep 25, 2026 | 2.27 | 2.27 | 2.03 | 2.03 | 38.10K |
| Sep 24, 2026 | 2.28 | 2.33 | 2.06 | 2.15 | 56.10K |
| Sep 23, 2026 | 2.23 | 2.38 | 2.12 | 2.14 | 68.70K |
| Sep 22, 2026 | 2.05 | 2.40 | 2.05 | 2.38 | 121.00K |
| Sep 21, 2026 | 1.98 | 2.23 | 1.98 | 2.15 | 138.90K |
| Sep 18, 2026 | 2.17 | 2.20 | 2.06 | 2.06 | 19.70K |
About Jyong Biotech
Jyong Biotech (MENS) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in NEW TAIPEI CITY. State of incorporation: Cayman Islands. Fiscal year ends —. SEC CIK 1954488.
MENS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Pang-Chieh Chi | Director | Apr 1, 2026 |
| Hung-Shu Fan | Director | Apr 1, 2026 |
| Feng-Lin Hsu | Director | Apr 1, 2026 |
| Ming Tsan Hsu | Director | Apr 1, 2026 |
| Fu-Feng Kuo | CEO | Apr 8, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Fu-Feng Kuo | CEO | Apr 8, 2026 |
| Wei (Vivi) Zhang | CFO | Apr 14, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
MENS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
MENS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on MENS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.